Aziz Mottiwala - Net Worth and Insider Trading
Aziz Mottiwala Net Worth
The estimated net worth of Aziz Mottiwala is at least $2 Million dollars as of 2024-11-05. Aziz Mottiwala is the Chief Commercial Officer of Tarsus Pharmaceuticals Inc and owns about 54,075 shares of Tarsus Pharmaceuticals Inc (TARS) stock worth over $2 Million. Details can be seen in Aziz Mottiwala's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Aziz Mottiwala has not made any transactions after 2024-03-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Aziz Mottiwala
Aziz Mottiwala Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Aziz Mottiwala owns 2 companies in total, including Tarsus Pharmaceuticals Inc (TARS) , and Opiant Pharmaceuticals Inc (OPNT) .
Click here to see the complete history of Aziz Mottiwala’s form 4 insider trades.
Insider Ownership Summary of Aziz Mottiwala
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TARS | Tarsus Pharmaceuticals Inc | 2024-03-18 | Chief Commercial Officer |
| OPNT | Opiant Pharmaceuticals Inc | 2019-09-20 | Chief Commercial Officer |
Aziz Mottiwala Latest Holdings Summary
Aziz Mottiwala currently owns a total of 1 stock. Aziz Mottiwala owns 54,075 shares of Tarsus Pharmaceuticals Inc (TARS) as of March 18, 2024, with a value of $2 Million.
Latest Holdings of Aziz Mottiwala
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TARS | Tarsus Pharmaceuticals Inc | 2024-03-18 | 54,075 | 45.66 | 2,469,065 |
Holding Weightings of Aziz Mottiwala
Aziz Mottiwala Form 4 Trading Tracker
According to the SEC Form 4 filings, Aziz Mottiwala has made a total of 12 transactions in Tarsus Pharmaceuticals Inc (TARS) over the past 5 years, including 0 buys and 12 sells. The most-recent trade in Tarsus Pharmaceuticals Inc is the sale of 4,766 shares on March 18, 2024, which brought Aziz Mottiwala around $145,840.
Insider Trading History of Aziz Mottiwala
- 1
Aziz Mottiwala Trading Performance
Aziz Mottiwala Ownership Network
Ownership Network List of Aziz Mottiwala
Ownership Network Relation of Aziz Mottiwala
Aziz Mottiwala Owned Company Details
What does Tarsus Pharmaceuticals Inc do?
Who are the key executives at Tarsus Pharmaceuticals Inc?
Aziz Mottiwala is the Chief Commercial Officer of Tarsus Pharmaceuticals Inc. Other key executives at Tarsus Pharmaceuticals Inc include See Remarks Jeffrey S Farrow , Chief Human Resources Officer Dianne C. Whitfield , and General Counsel Bryan Wahl .
Tarsus Pharmaceuticals Inc (TARS) Insider Trades Summary
Over the past 18 months, Aziz Mottiwala made 4 insider transaction in Tarsus Pharmaceuticals Inc (TARS) with a net sale of 11,909. Other recent insider transactions involving Tarsus Pharmaceuticals Inc (TARS) include a net sale of 240,415 shares made by Bobak R. Azamian , a net sale of 12,792 shares made by Bryan Wahl , and a net sale of 12,669 shares made by Dianne C. Whitfield .
In summary, during the past 3 months, insiders sold 35,000 shares of Tarsus Pharmaceuticals Inc (TARS) in total and bought 0 shares, with a net sale of 35,000 shares. During the past 18 months, 331,965 shares of Tarsus Pharmaceuticals Inc (TARS) were sold and 10,506 shares were bought by its insiders, resulting in a net sale of 321,459 shares.
Tarsus Pharmaceuticals Inc (TARS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tarsus Pharmaceuticals Inc Insider Transactions
Aziz Mottiwala Mailing Address
Above is the net worth, insider trading, and ownership report for Aziz Mottiwala. You might contact Aziz Mottiwala via mailing address: 233 Wilshire Boulevard, Suite 280, Santa Monica Ca 90401.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
